NMPA Approval

Ruxolitinib Phosphate Tablets

Approval Number

国药准字HJ20170130

Registration Date

December 7, 2021

Previous Approval Numbers

H20170130

Drug Information

Generic Name

磷酸芦可替尼片

Trade Name

捷恪卫

Dosage Form

片剂

Strength

15mg（以芦可替尼计）

Drug Type

化学药品

Registration Date

December 7, 2021

Expiry Date

December 6, 2026

Company Address

6343 Risch, Switzerland

Company Address

Schaffhauserstrasse 4332 Stein, Switzerland

Empowering clinical research with data-driven insights and AI-powered tools.

磷酸芦可替尼片 - NMPA 批准文号 | MedPath